A 10% Rise Could Be In Order

A 10% Rise Could Be In Order

The NASDAQ Composite has spent the first 6 trading days of August in a tight trading range. A breakout of this range will likely result in an extended move. …

Read More

A Quick 20% Profit on Perfume?

A Quick 20% Profit on Perfume?

While the major indexes took another hit on Friday, the charts of many quality stocks show possible reversals. Reversal candlestick patterns appeared, and the …

Read More

How Far Is This Decline Likely To Go?

How Far Is This Decline Likely To Go?

The drop in the Dow Jones Industrial Average, plunging below the 50-day moving average (MA) on a mission to visit the 200-day MA, makes a good headline. If we …

Read More

Are Semi Stocks At A Rebound Point?

Are Semi Stocks At A Rebound Point?

While the DJIA, the S&P 500, and the NASDAQ Composite are still sitting near highs, there is weakness showing up in some sectors that have recently been …

Read More

Will the Small Caps Take The Lead?

Will the Small Caps Take The Lead?

The S&P 500 has set a new all-time high, barely inching above the tight trading range of the past month. And the S&P 500 is the star index. While the NASDAQ …

Read More

What Do The Next Six Months Hold?

What Do The Next Six Months Hold?

The S&P 500 has traded sideways for three weeks now. Volume is not giving us a clue as to the direction it shall ultimately pick. The Stochastics indicator is …

Read More

The Dinner-Out Trade

The Dinner-Out Trade

Regular scanning of a handful of top sector ETFs can help you find breakouts just as they are starting. For example, on Thursday (7/3/14) the financial ETFs …

Read More

A Cup-with-handle Breakout

A Cup-with-handle Breakout

In the June 18th newsletter, I covered a good setup in Actavis (ACT), a generic drug manufacturer. I presented my case for a bullish trade in the stock, …

Read More

A Golden Opportunity Quickly Paying Off

A Golden Opportunity Quickly Paying Off

While it is a goal to select only the best trade candidates, the stocks backed by excellent fundamentals, seasonal track records and so forth, there are times …

Read More

How Far Will Stericycle Go?

How Far Will Stericycle Go?

In the June 2nd newsletter, I focused on Stericycle, saying… “Stericycle (SRCL) has been in a slight downtrend. The medical waste management …

Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.